
معرفی
Dr. Samantha Emery-Corbin is a Research Fellow and proteomics project lead in the Department of Biochemistry & Molecular Biology at Monash University. She has extensive expertise in mass spectrometry–based proteomics and leads a diverse portfolio of projects ranging from clinical cohort studies in type 1 diabetes to analyses of biofluids, tissues, and extracellular vesicles. She is an active Chief Investigator on multi-institutional research grants and is currently contributing to the MEGA-dose aSCORbatE for Sepsis (MEGASCORES) program, an interdisciplinary initiative aimed at transforming sepsis management in intensive care units.
Her research focuses on advancing proteomic technologies, particularly through pioneering data-independent acquisition workflows for unbiased drug-target profiling and subproteome mapping. Her work challenges existing paradigms in post-translational regulation, especially in parasitic organisms, and contributes to the UN Sustainable Development Goals through innovations in precision diagnostics and next-generation therapies.
The recent trend in her publications reflects a strong emphasis on clinical and translational proteomics. Her articles span aging and metabolic health, reproductive biology, hematology, and critical care device interactions. These works demonstrate a consistent application of quantitative proteomics to complex biological and medical questions, often in collaborative, interdisciplinary settings.
She has received notable recognition for her research, including:
- Jack Brockhoff Foundation ECR Fellowship (2016)
- Vice Chancellor’s Commendation for PhD Thesis (2016)
As a Chief Investigator on major grants like MEGASCORES, Dr. Emery-Corbin plays a key role in securing and managing research funding that supports collaborative science across institutions. She is currently accepting PhD students, indicating active mentorship and leadership in training the next generation of researchers. Her work is centered in advanced proteomics laboratories at Monash, where she leads technical and analytical teams focused on innovation in mass spectrometry applications.



